O ver the past 2 years, the results of large clinical trials have fundamentally changed the clinical practice of stroke care in several different ways. Perhaps the greatest advances have occurred in stroke prevention, where we now have a wider array of anticoagulants to reduce the risk of stroke in patients with atrial fibrillation and we have confirmation from 2 large studies that medical ther...

Christophe L. Dubois, MD,* Ann Belmans, MSC,*† Christopher B. Granger, MD, FACC,‡ Paul W. Armstrong, MD, FACC,§ Lars Wallentin, MD, FACC, Paolo M. Fioretti, MD, FACC,¶ José L. López-Sendón, MD, FACC,# Freek W. Verheugt, MD, FACC,** Jürgen Meyer, MD, FACC,†† Frans Van de Werf, MD, FACC,* on behalf of the ASSENT-3 Investigators Leuven, Belgium; Durham, North Carolina; Edmonton, Canada; Uppsala, S...

S ubstantial advances have been made during the past 2 years in various applications of neuroimaging in stroke. Because of limited space, a few major areas in imaging are highlighted here, including developments in selection for acute stroke therapies, hemorrhage, and recovery. Results from several clinical trials have provided important data about imaging selection, including the mismatch conc...